Vagus Nerve Stimulation Shows Age-Specific Effects on the Brain’s Immune Sentinel
A recent single-blind, sham-controlled crossover trial investigated how transcutaneous vagus nerve stimulation (VNS) affects the locus coeruleus-norepinephrine system, a key neuromodulatory pathway linked to neuroinflammation and immune regulation. Researchers measured task-evoked pupillary responses, a physiological proxy for locus coeruleus activity, in younger and older adults. The study found that VNS produced distinct, age-specific effects: older adults exhibited increased tonic pupil size and reduced oddball-evoked pupillary responses during stimulation, while younger adults showed no consistent changes. The findings suggest that baseline neuroimmune states, which change with age, significantly influence the physiological impact of VNS.
Why it might matter to you: This research directly intersects with neuroimmunology by demonstrating how a non-invasive neuromodulation technique can differentially influence a core brainstem nucleus involved in systemic inflammation and immune surveillance. For professionals focused on immunotherapy or neuroinflammatory conditions, these age-specific effects highlight a critical variable for designing targeted interventions. It suggests that therapeutic strategies aiming to modulate the immune-brain axis may need to be calibrated based on an individual’s neurophysiological age, potentially influencing the development of next-generation bioelectronic therapies for autoimmune and age-related disorders.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
